Symptomatic and asymptomatic viral recrudescence in solid-organ transplant recipients and its relationship with the antigen-specific CD8+ T-cell response

被引:39
作者
Crough, Tanta
Fazou, Chrysa
Weiss, Julissa
Campbell, Scott
Davenport, Miles P.
Bell, Scott C.
Galbraith, Andrew
McNeil, Keith
Khanna, Rajiv
机构
[1] Queensland Inst Med Res, Div Infect Dis & Immunol, Australian Ctr Vaccine Dev & Tumour Immunol Lab, Brisbane, Qld 4029, Australia
[2] Univ Queensland, Sch Med, Brisbane, Qld, Australia
[3] Univ New S Wales, Prince Wales Hosp, Ctr Vasc Res, Dept Haematol, Kensington, NSW 2052, Australia
[4] Univ Queensland, Prince Charles Hosp, Dept Med, Brisbane, Qld, Australia
[5] Univ Queensland, Princess Alexandra Hosp, Dept Nephrol, Dept Med, Brisbane, Qld, Australia
关键词
D O I
10.1128/JVI.00581-07
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学]; 100705 [微生物与生化药学];
摘要
Using ex vivo antigen-specific T-cell analysis, we found that symptomatic cytomegalovirus recrudescence in transplant recipients was coincident with reduced expression of gamma interferon (IFN-gamma) by virus-specific CD8(+) T cells and an up-regulation of CD38 expression on these T cells, although there was no significant change in the absolute number of virus-specific cells (as assessed by major histocompatibility complex-peptide multimers). In contrast, HLA class I-matched transplant patients with asymptomatic viral recrudescence showed increased expansion of antigen-specific T cells and highly stable IFN-gamma expression by epitope-specific T cells. These studies suggest that a strong functional T-cell response plays a crucial role in defining the clinical outcome of acute viral recrudescence.
引用
收藏
页码:11538 / 11542
页数:5
相关论文
共 20 条
[1]
Longitudinal dynamics of antigen-specific CD8+ cytotoxic T lymphocytes following primary Epstein-Barr virus infection [J].
Bharadwaj, M ;
Burrows, SR ;
Burrows, JM ;
Moss, DJ ;
Catalina, M ;
Khanna, R .
BLOOD, 2001, 98 (08) :2588-2589
[2]
Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo [J].
Callan, MFC ;
Tan, L ;
Annels, N ;
Ogg, GS ;
Wilson, JDK ;
O'Callaghan, CA ;
Steven, N ;
McMichael, AJ ;
Rickinson, AB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (09) :1395-1402
[3]
Contemporaneous fluctuations in T cell responses to persistent herpes virus infections [J].
Crough, T ;
Burrows, JM ;
Fazou, C ;
Walker, S ;
Davenport, MP ;
Khanna, R .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (01) :139-149
[4]
Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers [J].
Elkington, R ;
Walker, S ;
Crough, T ;
Menzies, M ;
Tellam, J ;
Bharadwaj, M ;
Khanna, R .
JOURNAL OF VIROLOGY, 2003, 77 (09) :5226-5240
[5]
Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments [J].
Gandhi, MK ;
Khanna, R .
LANCET INFECTIOUS DISEASES, 2004, 4 (12) :725-738
[6]
Monitoring of human cytomegalovirus-specific CD4+ and CD8+ T-cell immunity in patients receiving solid organ transplantation [J].
Gerna, G. ;
Lilleri, D. ;
Fornara, C. ;
Comolli, G. ;
Lozza, L. ;
Campana, C. ;
Pellegrini, C. ;
Meloni, F. ;
Rampino, T. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (10) :2356-2364
[7]
Gerna Giuseppe, 2006, Herpes, V13, P4
[9]
Human cytomegalovirus vaccine: time to look for alternative options [J].
Khanna, R ;
Diamond, DJ .
TRENDS IN MOLECULAR MEDICINE, 2006, 12 (01) :26-33
[10]
Technology Insight: applications of emerging immunotherapeutic strategies for Epstein-Barr virus-associated malignancies [J].
Khanna, R ;
Moss, D ;
Gandhi, M .
NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (03) :138-149